文献速递神经肿瘤

CCL2-CCR4轴促进调节性T细胞向犬胶质瘤组织迁移

The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues.
PubMed 文献 · J Neurooncol · 2024-07-24

研究以宠物犬自发高级别胶质瘤为人类胶质母细胞瘤的转化模型,用犬调节性T细胞与患者来源犬胶质瘤细胞系进行体外实验,探讨CCL2-CCR4信号轴。结果显示犬CD4+CD25high T细胞高表达FOXP3和CCR4,CCL2或胶质瘤细胞系上清增强犬Treg迁移,阻断CCL2-CCR4轴显著减少迁移;CCL2 mRNA在所有胶质瘤细胞系中表达,暴露于Treg后表达增加。结论认为该轴在犬高级别胶质瘤中为双向的Treg-胶质瘤免疫抑制与促肿瘤轴。

要点

  • 犬CD4+CD25high T细胞群高富集FOXP3与CCR4表达,为真正的Treg。
  • CCL2或胶质瘤细胞系来源上清增强犬Treg迁移,阻断CCL2-CCR4轴显著减少迁移。
  • CCL2 mRNA在所有胶质瘤细胞系中表达,暴露于Treg后表达增加,而CD4+辅助性T细胞无此作用。

核心结论

  • 研究验证CCL2-CCR4在犬高级别胶质瘤中为双向的Treg-胶质瘤免疫抑制与促肿瘤轴。

研究设计与样本

  • 采用犬Treg与患者来源犬胶质瘤细胞系(GSC 1110、GSC 0514、J3T-Bg、G06A)进行系列体外实验,探究犬CCL2-CCR4信号轴。

主要发现

  • 建立流式细胞术设门策略以识别和分离犬FOXP3+ Treg。
  • 犬CD4+CD25high T细胞群高富集FOXP3与CCR4表达,表明其为真正的Treg。
  • 犬Treg迁移可被CCL2或胶质瘤细胞系来源上清增强。
  • 阻断CCL2-CCR4轴显著减少犬Treg迁移。
  • CCL2 mRNA在所有胶质瘤细胞系中表达,暴露于Treg后表达增加,而暴露于CD4+辅助性T细胞后不增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Spontaneously occurring glioma in pet dogs is increasingly recognized as a valuable translational model for human glioblastoma. Canine high-grade glioma and human glioblastomas share many molecular similarities, including the accumulation of immunosuppressive regulatory T cells (Tregs) that inhibit anti-tumor immune responses. Identifying in dog mechanisms responsible for Treg recruitment may afford to target the cellular population driving immunosuppression, the results providing a rationale for translational clinical studies in human patients. Our group has previously identified C-C motif chemokine 2 (CCL2) as a glioma-derived T-reg chemoattractant acting on chemokine receptor 4 (CCR4) in a murine orthotopic glioma model. Recently, we demonstrated a robust increase of CCL2 in the brain tissue of canine patients bearing high-grade glioma. METHODS: We performed a series of in vitro experiments using canine Tregs and patient-derived canine glioma cell lines (GSC 1110, GSC 0514, J3T-Bg, G06A) to interrogate the CCL2-CCR4 signaling axis in the canine. RESULTS: We established a flow cytometry gating strategy for identifying and isolating FOXP3+ Tregs in dogs. The canine CD4 + CD25high T-cell population was highly enriched in FOXP3 and CCR4 expression, indicating they are bona fide Tregs. Canine Treg migration was enhanced by CCL2 or by glioma cell line-derived supernatant. Blockade of the CCL2-CCR4 axis significantly reduced migration of canine Tregs. CCL2 mRNA was expressed in all glioma cell lines, and expression increased when exposed to Tregs but not CD4 + helper T-cells. CONCLUSION: Our study validates CCL2-CCR4 as a bi-directional Treg-glioma immunosuppressive and tumor-promoting axis in canine high-grade glioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Panek WK, Toedebusch RG, Mclaughlin BE, et al. The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues. J Neurooncol. 2024. PMID: 39046599. doi:10.1007/s11060-024-04766-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。